000538 云南白药
已收盘 07-10 15:00:00
资讯
新帖
简况
云南白药:7月9日接受机构调研,平安基金、信达证券参与
证券之星 · 11:03
云南白药:7月9日接受机构调研,平安基金、信达证券参与
云南白药中标普洱市中医医院中药饮片代煎服务项目 赋能区域性中医药服务智能化升级
云南白药 · 06-30
云南白药中标普洱市中医医院中药饮片代煎服务项目 赋能区域性中医药服务智能化升级
云白国际(00030):于泰国生产的以“云南白药”为品牌名称的首批牙膏产品 顺利在中国内地以外销售
智通财经网 · 06-29
云白国际(00030):于泰国生产的以“云南白药”为品牌名称的首批牙膏产品 顺利在中国内地以外销售
每周股票复盘:云南白药(000538)核药研发及一季度业绩表现亮眼
证券之星 · 06-28
每周股票复盘:云南白药(000538)核药研发及一季度业绩表现亮眼
云南白药集团健康产品有限公司6月28日新增投诉,消费者要求退货,退赔费用
金融界 · 06-28
云南白药集团健康产品有限公司6月28日新增投诉,消费者要求退货,退赔费用
云南白药股价微涨0.83%,董事会通过七甸产业区饮片生产中心建设项目
金融界 · 06-25
云南白药股价微涨0.83%,董事会通过七甸产业区饮片生产中心建设项目
云南白药:6月20日接受机构调研,长江证券、永赢基金等多家机构参与
证券之星 · 06-24
云南白药:6月20日接受机构调研,长江证券、永赢基金等多家机构参与
AMAC医药制造指数上涨1.01%,前十大权重包含云南白药等
金融界 · 06-23
AMAC医药制造指数上涨1.01%,前十大权重包含云南白药等
云南白药:6月19日接受机构调研,中信证券、中金公司等多家机构参与
证券之星 · 06-23
云南白药:6月19日接受机构调研,中信证券、中金公司等多家机构参与
云白国际(00030)获云南白药全球(除中国内地外)独家经销权
智通财经 · 06-18
云白国际(00030)获云南白药全球(除中国内地外)独家经销权
【云南白药:JZ-14胶囊获溃疡性结肠炎临床试验批准】云南白药公告,控股子公司征武科技收到国家药品监督管理局下发的《药物临床试验批准通知书》,同意JZ-14胶囊开展溃疡性结肠炎的临床试验。
金融界 · 06-17
【云南白药:JZ-14胶囊获溃疡性结肠炎临床试验批准】云南白药公告,控股子公司征武科技收到国家药品监督管理局下发的《药物临床试验批准通知书》,同意JZ-14胶囊开展溃疡性结肠炎的临床试验。
云南白药集团将亮相第9届南博会中药材产业馆
云南白药 · 06-13
云南白药集团将亮相第9届南博会中药材产业馆
中药龙头云南白药VS同仁堂VS片仔癀多角度对比分析
药事纵横 · 06-11
中药龙头云南白药VS同仁堂VS片仔癀多角度对比分析
中证中药指数上涨0.31%,前十大权重包含云南白药等
金融界 · 06-11
中证中药指数上涨0.31%,前十大权重包含云南白药等
云南白药:上市公司现金分红是切实提升投资者获得感的重要方式
证券之星 · 05-30
云南白药:上市公司现金分红是切实提升投资者获得感的重要方式
【云南白药投资成立中药材开发公司】公开资料显示,近日,云南白药集团中药材开发(巍山)有限公司成立,法定代表人为王煜,注册资本2000万元,经营范围包含:药品批发;药品零售;药品生产;农作物种子经营;地产中草药(不含中药饮片)购销;食用农产品批发等。股权数据显示,该公司由云南白药间接全资持股。
金融界 · 05-27
【云南白药投资成立中药材开发公司】公开资料显示,近日,云南白药集团中药材开发(巍山)有限公司成立,法定代表人为王煜,注册资本2000万元,经营范围包含:药品批发;药品零售;药品生产;农作物种子经营;地产中草药(不含中药饮片)购销;食用农产品批发等。股权数据显示,该公司由云南白药间接全资持股。
华东建筑设计研究院有限公司中标云南白药中医药产业文化园项目
DoNews · 05-26
华东建筑设计研究院有限公司中标云南白药中医药产业文化园项目
每周股票复盘:云南白药(000538)2024年药品业务增长显著,牙膏市场份额第一
证券之星 · 05-24
每周股票复盘:云南白药(000538)2024年药品业务增长显著,牙膏市场份额第一
云南白药:5月19日接受机构调研,Orient Securities Company Limited、Matthews International Capital Management LLC参与
证券之星 · 05-21
云南白药:5月19日接受机构调研,Orient Securities Company Limited、Matthews International Capital Management LLC参与
云南白药:药品事业群销售过亿的重要产品达10个,气雾剂收入突破21亿元
财经网 · 05-16
云南白药:药品事业群销售过亿的重要产品达10个,气雾剂收入突破21亿元
加载更多
公司概况
公司名称:
云南白药集团股份有限公司
所属行业:
医药制造业
上市日期:
1993-12-15
主营业务:
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。公司荣登BrandFinance发布的《全球最具价值与最强医药、医疗器械及医疗服务品牌价值排行榜》25强,美国《制药经理人》杂志公布的《全球制药企业50强排行榜》第33位,Interbrand发布的《中国最佳品牌排行榜》第45位,《凯度BrandZ最具价值中国品牌100强》排行榜第71位,医疗保健行业第1位。
发行价格:
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":56,"timestamp":1752131031000,"preClose":56.04,"halted":0,"volume":4845710,"delay":0,"changeRate":-0.0007,"floatShares":1773000000,"shares":1784000000,"eps":2.7923,"marketStatus":"已收盘","change":-0.04,"latestTime":"07-10 15:00:00","open":56.04,"high":56.11,"low":55.86,"amount":271000000,"amplitude":0.0045,"askPrice":56,"askSize":161,"bidPrice":55.99,"bidSize":177,"shortable":0,"etf":0,"ttmEps":2.7923,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752197400000},"marketStatusCode":5,"adr":0,"adjPreClose":56.04,"symbolType":"stock","openAndCloseTimeList":[[1752111000000,1752118200000],[1752123600000,1752130800000]],"highLimit":61.64,"lowLimit":50.44,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.45,"roa":"--","peRate":20.055152,"roe":"4.86%","epsLYR":2.66,"committee":-0.047059,"marketValue":99919000000,"turnoverRate":0.0027,"status":1,"floatMarketCap":99271000000},"requestUrl":"/m/hq/s/000538","defaultTab":"news","newsList":[{"id":"2550644992","title":"云南白药:7月9日接受机构调研,平安基金、信达证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2550644992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550644992?lang=zh_cn&edition=full","pubTime":"2025-07-10 19:03","pubTimestamp":1752145386,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年7月10日云南白药发布公告称公司于2025年7月9日接受机构调研,平安基金王华 丁琳、信达证券章钟涛 王留阳参与。云南白药的渠道优势极大提升了公司的市场竞争能力,同时为持续的新产品商业化开发奠定了基础。云南白药主营业务:自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000031606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0012","000538","BK0187","BK0164","601059","BK0175","BK0239","BK0188","BK0276"],"gpt_icon":0},{"id":"2547093641","title":"云南白药中标普洱市中医医院中药饮片代煎服务项目 赋能区域性中医药服务智能化升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2547093641","media":"云南白药","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547093641?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:53","pubTimestamp":1751277236,"startTime":"0","endTime":"0","summary":"2025年6月18日,云南白药集团在普洱市中医医院中药饮片代煎服务项目中成功中标。普洱市中医医院此次中标肯定了云南白药在云南省中医药服务领域的行业的领先和示范效应,也为普洱市中医药服务的现代化发展升级注入了新动能。未来云南白药集团将持续深化与普洱市中医医院以及普洱市中医医疗集团的战略合作,充分发挥中医药“简、便、廉、验”的独特优势,为人民群众的健康保驾护航。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630184355a725f25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630184355a725f25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000538","BK0239","561510","562390","BK0196","BK0164","BK0187","BK0175","BK0012","BK0188","BK0028"],"gpt_icon":0},{"id":"2547033735","title":"云白国际(00030):于泰国生产的以“云南白药”为品牌名称的首批牙膏产品 顺利在中国内地以外销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2547033735","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547033735?lang=zh_cn&edition=full","pubTime":"2025-06-30 07:42","pubTimestamp":1751240540,"startTime":"0","endTime":"0","summary":"智通财经APP讯,云白国际(00030)发布公告,由公司安排于泰国生产的以“云南白药”为品牌名称的首批牙膏产品,已由公司顺利在中国内地以外销售。这是于中国内地以外生产的以“云南白药”为品牌名称的牙膏产品首次投入销售。该里程碑标志着公司的战略扩张迈出重要一步,亦彰显向其国际客户提供优质产品的承诺,符合公司提升生产效率及充分利用国际制造业专业知识的愿景。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1600","BK1121","000538","BK0028","BK0196","BK0188","BK0239","BK0164","BK0187","BK0175","00030","BK0012"],"gpt_icon":0},{"id":"2547706403","title":"每周股票复盘:云南白药(000538)核药研发及一季度业绩表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2547706403","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547706403?lang=zh_cn&edition=full","pubTime":"2025-06-29 03:34","pubTimestamp":1751139252,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘,云南白药报收于55.88元,较上周的55.03元上涨1.54%。本周,云南白药6月26日盘中最高价报56.38元。本周关注点机构调研要点:云南白药核药研发体系具备强大研发能力、产业链整合能力及前瞻性战略布局。业绩披露要点:2025年第一季度,云南白药实现营业收入108.41亿元,同比增长0.62%;归母净利润19.35亿元,同比增长13.67%。公司公告汇总:云南白药全资子公司云核医药的INR102注射液获得国家药品监督管理局临床试验批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900000583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0239","BK0196","BK0164","BK0028","BK0187","BK0012","BK0188","BK0175"],"gpt_icon":0},{"id":"2546777107","title":"云南白药集团健康产品有限公司6月28日新增投诉,消费者要求退货,退赔费用","url":"https://stock-news.laohu8.com/highlight/detail?id=2546777107","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546777107?lang=zh_cn&edition=full","pubTime":"2025-06-28 19:14","pubTimestamp":1751109241,"startTime":"0","endTime":"0","summary":"6月28日,根据全国12315消费投诉信息公示,云南白药集团健康产品有限公司新增投诉。可能存在合同->经营者拒不履行合同约定问题,要求退货,退赔费用。2025年6月28日,双方自行和解或者投诉人撤回投诉。天眼查商业履历信息显示,云南白药集团健康产品有限公司成立于1991年1月1日,位于昆明经济技术开发区经邮路6号,是一家以从事医药制造业为主的企业,企业注册资本8450万人民币,法定代表人为李胜利。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/28191451372667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0175","BK0196","BK0012","BK0187","BK0188","BK0164","BK0028","000538","BK0239"],"gpt_icon":0},{"id":"2546423322","title":"云南白药股价微涨0.83%,董事会通过七甸产业区饮片生产中心建设项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2546423322","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546423322?lang=zh_cn&edition=full","pubTime":"2025-06-25 23:53","pubTimestamp":1750866822,"startTime":"0","endTime":"0","summary":"截至2025年6月25日15时,云南白药股价报55.86元,较前一交易日上涨0.83%。当日成交额3.35亿元,换手率0.34%,总市值996.69亿元。云南白药主营业务涵盖商业销售、工业销售等,其中商业销售占比63.63%,工业销售占比36.14%。公司所属行业包括中药、云南板块等。消息面上,云南白药董事会审议通过了七甸产业区饮片生产中心建设项目,并讨论了上海医药集团2024年年度股东大会议案表决意见等事项。资金方面,6月25日主力资金净流出1321.63万元。风险提示:市场有风险,投资需谨慎。\n\n\r\n 责任编辑:磐石","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/25235351310515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0187","BK0164","000538","BK0196","BK0239","BK0175","BK0012","BK0028","BK0188"],"gpt_icon":0},{"id":"2545282366","title":"云南白药:6月20日接受机构调研,长江证券、永赢基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2545282366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545282366?lang=zh_cn&edition=full","pubTime":"2025-06-24 20:06","pubTimestamp":1750766765,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年6月24日云南白药发布公告称公司于2025年6月20日接受机构调研,长江证券张楠、永赢基金张蕊、华能贵诚杨成、拾贝投资陈问、嘉富行远张丰、人保资产宋雅慧 张维亮、九泰基金赵万隆参与。2025年5月,云核医药在天津顺利召开INR102注射液I/IIa期临床试验中心启动会,该研发项目正式迈入临床转化新阶段。该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为67.99。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400034961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0196","BK0012","BK0187","BK0276","BK0188","BK0164","BK0028","000538","BK0239","BK0183","000783","BK0201"],"gpt_icon":0},{"id":"2545944337","title":"AMAC医药制造指数上涨1.01%,前十大权重包含云南白药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2545944337","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545944337?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:47","pubTimestamp":1750690036,"startTime":"0","endTime":"0","summary":"金融界6月23日消息,上证指数低开高走,AMAC医药制造指数 上涨1.01%,报4295.51点,成交额556.83亿元。数据统计显示,AMAC医药制造指数近一个月上涨1.76%,近三个月上涨6.11%,年至今上涨7.72%。从指数持仓来看,AMAC医药制造指数十大权重分别为:恒瑞医药、片仔癀、云南白药、科伦药业、上海莱士、新和成、长春高新、常山药业、复星医药、百济神州。从AMAC医药制造指数持仓样本的行业来看,医药卫生占比97.99%、主要消费占比1.94%、工业占比0.07%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/23224751249127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0012","BK0188","399233","BK1161","BK1515","159938","BK0239","09939","BK0028","BK0164","000538","BK0175","BK0187","BK0196","BK1574"],"gpt_icon":0},{"id":"2545415289","title":"云南白药:6月19日接受机构调研,中信证券、中金公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2545415289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545415289?lang=zh_cn&edition=full","pubTime":"2025-06-23 19:01","pubTimestamp":1750676514,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年6月23日云南白药发布公告称公司于2025年6月19日接受机构调研,中信证券李文涛、中金公司朱言音、平安证券韩盟盟 曹艳凯、圆和资本陈家华参与。)临床试验申请符合药品注册的有关要求,同意本品开展前列腺癌的临床试验。该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为67.99。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300025634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU2495084118.USD","LU1997245094.SGD","BK0183","BK0239","SG9999002828.SGD","BK0196","LU1794554557.SGD","BK0276","600030","LU1997244956.HKD","BK1521","BK1516","LU0405327494.USD","BK0187","LU1720050803.USD","BK0188","03908","BK0028","BK1564","601995","LU1064131003.USD","LU1064130708.USD","LU2289578879.USD","BK1147","LU1655091616.SGD","BK0164","06030","BK0175","LU0405327148.USD","LU1328615791.USD","BK1501","LU1997245177.USD","000538","LU2148510915.USD"],"gpt_icon":0},{"id":"2544920953","title":"云白国际(00030)获云南白药全球(除中国内地外)独家经销权","url":"https://stock-news.laohu8.com/highlight/detail?id=2544920953","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544920953?lang=zh_cn&edition=full","pubTime":"2025-06-18 17:32","pubTimestamp":1750239138,"startTime":"0","endTime":"0","summary":"智通财经APP讯,云白国际(00030)发布公告,公司近期获授独家经销授权,可于全球(除中国内地外)经销其控股股东云南白药集团股份有限公司所持有╱生产╱销售的产品。公司有权在授权范围内作为云南白药集团的产品经销商对产品进行销售、推广、管理及其他合法商业活动,包括但不限于产品定价、营销策略及渠道选择。公司亦可将授权项下获授的权利进行转授权,以满足其业务发展需要。授权产品包括但不限于“云南白药”系列药品、“云南白药”牙膏系列产品、普通药品系列产品、医疗器械及工业产品以及个人护理产品。公告称,此项安排将可利用云南白药集团的成熟品牌及产品组合,提升公司的市场地位及收入来源。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00030","BK0028","BK1600","BK0239","BK0012","BK0196","BK0164","BK1121","BK0188","000538","BK0175","BK0187"],"gpt_icon":0},{"id":"2544981966","title":"【云南白药:JZ-14胶囊获溃疡性结肠炎临床试验批准】云南白药公告,控股子公司征武科技收到国家药品监督管理局下发的《药物临床试验批准通知书》,同意JZ-14胶囊开展溃疡性结肠炎的临床试验。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544981966","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544981966?lang=zh_cn&edition=full","pubTime":"2025-06-17 18:23","pubTimestamp":1750155789,"startTime":"0","endTime":"0","summary":"云南白药公告,控股子公司征武科技收到国家药品监督管理局下发的《药物临床试验批准通知书》,同意JZ-14胶囊开展溃疡性结肠炎的临床试验。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17182351122626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1576","BK0028","JZ","BK0175","BK0164","BK0239","BK1583","000538","BK0012","03347","BK1141","BK0188","BK0187","BK4204","BK0196"],"gpt_icon":0},{"id":"2543504253","title":"云南白药集团将亮相第9届南博会中药材产业馆","url":"https://stock-news.laohu8.com/highlight/detail?id=2543504253","media":"云南白药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543504253?lang=zh_cn&edition=full","pubTime":"2025-06-13 17:01","pubTimestamp":1749805296,"startTime":"0","endTime":"0","summary":"6月19日至24日,第9届中国—南亚博览会将在云南省昆明市举办。作为本届南博会战略合作伙伴,云南白药集团将亮相本届南博会首次设立的中药材产业馆,以“云南好药材,中国好中药”为主题打造上千平方米的沉浸式展区,推动全球中医药产业交流合作。另外,云南白药集团将在现场展示中药传统文化,并同步展示云南白药集团医疗器械板块产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613170352a4a70657&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613170352a4a70657&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","562390","BK0175","BK0196","BK0187","561510","BK0028","BK0239","BK0164","BK0012","000538"],"gpt_icon":0},{"id":"2542558924","title":"中药龙头云南白药VS同仁堂VS片仔癀多角度对比分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2542558924","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542558924?lang=zh_cn&edition=full","pubTime":"2025-06-12 06:02","pubTimestamp":1749679358,"startTime":"0","endTime":"0","summary":"云南白药、同仁堂和片仔癀是国内知名的三家中药龙头企业,云南白药以止血类和健康消费品种为主,其市值也位于中药行业前列。云南白药、片仔癀、同仁堂以营收均呈增长趋势。目前来看2025年云南白药的总资产周转是最快的预计达到0.8,同仁堂和片仔癀则相差不大。研发人员占比从研发员工情况数据来看,云南白药、同仁堂、片仔癀这个三家的研发人数对比2023年研发人数分别小幅度增加,说明研发团队规模近年基本稳定,未出现大规模增减。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612060438a7042ba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612060438a7042ba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0164","BK0183","000538","BK0188","BK0196","BK0239","561510","600436","BK0086","BK0113","562390","BK0187","LU1688375341.USD","BK0175","BK0028","BK0097","600085","BK0012"],"gpt_icon":0},{"id":"2542586188","title":"中证中药指数上涨0.31%,前十大权重包含云南白药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2542586188","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542586188?lang=zh_cn&edition=full","pubTime":"2025-06-11 19:05","pubTimestamp":1749639941,"startTime":"0","endTime":"0","summary":"金融界6月11日消息,上证指数高开高走,中证中药指数 上涨0.31%,报10060.72点,成交额124.74亿元。数据统计显示,中证中药指数近一个月上涨4.21%,近三个月上涨4.46%,年至今下跌1.20%。据了解,中证中药指数选取涉及中药生产与销售等业务的上市公司证券作为样本,以反映中药概念类上市公司的整体表现。该指数以2004年12月31日为基日,以1000.0点为基点。从中证中药指数持仓样本的行业来看,医药卫生占比100.00%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/11190551012147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000538","BK0175","BK0187","BK0196","BK0028","BK0164","BK0188","BK0239","BK0012"],"gpt_icon":0},{"id":"2539239552","title":"云南白药:上市公司现金分红是切实提升投资者获得感的重要方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2539239552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539239552?lang=zh_cn&edition=full","pubTime":"2025-05-30 17:54","pubTimestamp":1748598851,"startTime":"0","endTime":"0","summary":"证券之星消息,云南白药05月30日在投资者关系平台上答复投资者关心的问题。谢谢云南白药回复:您好!上市公司现金分红,是切实提升投资者获得感的重要方式,体现了企业责任与社会价值的双向流动。《上市公司监管指引第3号——上市公司现金分红》对上市公司现金分红相关事项进行了明确规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053000028976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0188","BK0012","BK0196","BK0028","BK0187","000538","BK0175","BK0239"],"gpt_icon":0},{"id":"2538439909","title":"【云南白药投资成立中药材开发公司】公开资料显示,近日,云南白药集团中药材开发(巍山)有限公司成立,法定代表人为王煜,注册资本2000万元,经营范围包含:药品批发;药品零售;药品生产;农作物种子经营;地产中草药(不含中药饮片)购销;食用农产品批发等。股权数据显示,该公司由云南白药间接全资持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538439909","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538439909?lang=zh_cn&edition=full","pubTime":"2025-05-27 13:37","pubTimestamp":1748324266,"startTime":"0","endTime":"0","summary":"公开资料显示,近日,云南白药集团中药材开发(巍山)有限公司成立,法定代表人为王煜,注册资本2000万元,经营范围包含:药品批发;药品零售;药品生产;农作物种子经营;地产中草药(不含中药饮片)购销;食用农产品批发等。股权数据显示,该公司由云南白药间接全资持股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/27133750676367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0164","BK0028","BK0016","BK0012","000061","BK0188","BK0210","BK0175","BK0196","BK0239","000538","BK0187","BK0027"],"gpt_icon":0},{"id":"2538141120","title":"华东建筑设计研究院有限公司中标云南白药中医药产业文化园项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2538141120","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538141120?lang=zh_cn&edition=full","pubTime":"2025-05-26 15:30","pubTimestamp":1748244603,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年5月26日,云南省省云南白药集团股份有限公司发布了关于云南白药中医药产业文化园项目建筑外立面效果提升方案设计的中标结果公示。该项目经过公开招标,最终确定华东建筑设计研究院有限公司为第一中标候选人。此次招标吸引了包括基准方中建筑设计股份有限公司、梁黄顾建筑设计(深圳)有限公司等多家单位参与投标。开标时间为2025年5月19日09时30分,评标委员会由7人组成。目前正处于公示期,时间为2025年5月26日至2025年5月28日,如有异议可向招标代理机构提出。免责声明:本文内容由开放的智能模型自动生成,仅供参考。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505261533119502cc69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505261533119502cc69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["562390","BK0012","BK0188","BK0239","BK0187","BK0028","000538","BK0196","BK0164","561510","BK0175"],"gpt_icon":0},{"id":"2537646481","title":"每周股票复盘:云南白药(000538)2024年药品业务增长显著,牙膏市场份额第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2537646481","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537646481?lang=zh_cn&edition=full","pubTime":"2025-05-24 12:37","pubTimestamp":1748061429,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,云南白药报收于56.58元,较上周的56.73元下跌0.26%。本周,云南白药5月21日盘中最高价报57.84元。答:药品事业群2024年主营业务收入69.24亿元,同比增长11.8%,单品销售过亿产品达10个。品牌打造方面,入选2024年云南省“绿色云品”品牌目录、“2024中药饮片品牌企业”及“2024道地药材品牌”。公司具有覆盖到终端的、布局完善的全国性大健康产品销售团队,云南白药牙膏市场份额在国内继续保持领先,在口腔品类拥有较高品牌渗透力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400011652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0188","000538","BK0239","BK0012","BK0028","BK0175","BK0196","BK0164"],"gpt_icon":0},{"id":"2537982030","title":"云南白药:5月19日接受机构调研,Orient Securities Company Limited、Matthews International Capital Management LLC参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2537982030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537982030?lang=zh_cn&edition=full","pubTime":"2025-05-21 19:17","pubTimestamp":1747826223,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年5月21日云南白药发布公告称公司于2025年5月19日接受机构调研,Orient Securities Company LimitedLili Guan Feng Li Kewen Li、Matthews International Capital Management LLCSherwood Zhang参与。植物补益类产品,气血康口服液销售收入继续保持增长态势,同口径下同比增长约14%。公司具有覆盖到终端的、布局完善的全国性大健康产品销售团队,云南白药牙膏市场份额在国内继续保持领先,在口腔品类拥有较高品牌渗透力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100033026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0012","BK0239","BK0187","BK0188","BK0196","BK0028","000538","BK0175"],"gpt_icon":0},{"id":"2536275324","title":"云南白药:药品事业群销售过亿的重要产品达10个,气雾剂收入突破21亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536275324","media":"财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536275324?lang=zh_cn&edition=full","pubTime":"2025-05-17 07:28","pubTimestamp":1747438086,"startTime":"0","endTime":"0","summary":"5月16日,云南白药参与2024年度云南辖区上市公司投资者网上集体接待日。期间管理层介绍,2024年,公司药品事业群重要单品销售过亿产品达10个。核心系列产品中,云南白药气雾剂销售收入突破21亿元,同比增长超26%;云南白药膏、云南白药胶囊、云南白药创可贴、云南白药(散剂)均在上年销售收入基础上,实现显著增长。植物补益类产品,气血康口服液销售收入继续保持增长态势,同口径下同比增长约14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517073455a4817137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517073455a4817137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0187","562390","BK0239","BK0175","000538","BK0188","BK0196","BK0012","561510","BK0164"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752181259966,"stockEarnings":[{"period":"1week","weight":0.0032},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0052},{"period":"6month","weight":0.0098},{"period":"1year","weight":0.1445},{"period":"ytd","weight":-0.0463}],"compareEarnings":[{"period":"1week","weight":0.014},{"period":"1month","weight":0.0369},{"period":"3month","weight":0.0838},{"period":"6month","weight":0.1077},{"period":"1year","weight":0.194},{"period":"ytd","weight":0.0471}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"170416人(较上一季度增加5.11%)","perCapita":"10402股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。公司荣登BrandFinance发布的《全球最具价值与最强医药、医疗器械及医疗服务品牌价值排行榜》25强,美国《制药经理人》杂志公布的《全球制药企业50强排行榜》第33位,Interbrand发布的《中国最佳品牌排行榜》第45位,《凯度BrandZ最具价值中国品牌100强》排行榜第71位,医疗保健行业第1位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}